Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Proceedings

Open Access

A staged strategy for pathogen surveillance and discovery

  • W Ian Lipkin1Email author,
  • Thomas Briese1,
  • Gustavo Palacios1,
  • Phuong-Lan Quan1,
  • Kirsi Honkavuori1,
  • Mady Hornig1,
  • Craig Street1 and
  • Omar Jabado1
BMC Proceedings20082(Suppl 1):S28

https://doi.org/10.1186/1753-6561-2-s1-s28

Published: 23 September 2008

Recent advances in molecular diagnostics have revolutionized microbiology by facilitating rapid, sensitive pathogen surveillance and differential diagnosis of infectious diseases. Implementation of these technologies can enable intervention when the prognosis is optimal for limiting replication, dissemination, transmission, morbidity and mortality. It may also reveal unappreciated links between infection and chronic diseases. Although new pathogens continue to emerge, we have likely collected much of the "low hanging fruit" (microbes readily associated with diseases). An important task now is to understand those disorders that reflect the interaction of microbes with other environmental factors (toxins, other stressors) and susceptibility genes in a developmental context. Here I will review the strengths and limitations of various assay platforms, describe the challenges associated with proving causation, and delineate a staged strategy for pathogen discovery focused in emerging infectious disease "hot spots," "hot hosts," and prospective birth cohorts.

Authors’ Affiliations

(1)
Center for Infection and Immunity, Columbia University

References

  1. Lipkin WI: Pathogen Discovery. PLoS Pathog. 2008, 4: e1000002-10.1371/journal.ppat.1000002.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Lipkin et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement